Guidance

Live attenuated influenza vaccine: patient group direction (PGD) template

PGD template to support the administration of live attenuated influenza vaccine (Fluenz Trivalent®) in accordance with the national seasonal influenza vaccination programme.

From:
UK Health Security Agency
Published
10 July 2024
Last updated
1 July 2025 바카라 사이트� See all updates

Applies to England

Documents

MS Word Document, 1.43 MB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD template supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent®) as part of the national seasonal influenza vaccination programme.

LAIV PGD version 15.00 is valid from 1 September 2025 to 1 April 2026.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see ).

This PGD template should be used with reference to current national guidance, the Green Book, and  for the vaccine.

Updates to this page

Published 10 July 2024
Last updated 1 July 2025 show all updates

  1. Added version 15, see page 4 for change history.

  2. First published.

Sign up for emails or print this page

Related content